Information about Cladribine
Cladribine is used in the treatment of Ovarian cancer, Head and neck cancer, Cervical cancer, Testicular cancer., Breast cancer, non-Hodgkin lymphoma (NHL), Blood cancer, Lung cancer, Bone cancer and Urinary bladder cancer.
How cladribine works
Cladribine interferes with the growth of DNA and RNA of the cancer cells by substituting their building blocks. It prevents the cancer cells from growing and multiplying.
Common side effects of cladribine
Nausea, Fatigue, Headache, Rash, Fever, Injection site allergic reaction
Available Medicine for Cladribine
- ₹12182Fresenius Kabi India Pvt Ltd1 variant(s)
Expert advice for Cladribine
- Cladribine is not recommended for use in children.
- Men should not father a child until at least 6 months after the last dose of cladribine.
- Your liver and kidney function should be monitored if you ever had liver, bone marrow or kidney problems or are suffering from any infection or fever.
- Tell your doctor before taking cladribine if you are already been given live vaccine or antiviral drugs like didanosine, tenofovir, adefovir etc.
- Do not drive or operate machinery as cladribine may make you dizzy.
Frequently asked questions for Cladribine
Q. Is Cladribine a vesicant?
Cladribine is not a vesicant (a chemical compound that causes severe skin, eye and mucosal pain and irritation)
Q. Is Cladribine FDA approved?
Yes, Cladribine was approved by US FDA in 2004 to treat hairy cell leukemia (type of white blood cell cancer)
Q. Does Cladribine cause hair loss?
No, Cladribine does not cause hair loss.